Information for Orforglipron
Page information·measured at build time
Technical and provenance information about Orforglipron. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Orforglipron |
|---|---|
| Default sort key | Orforglipron |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 5,647 |
| Rendered word count | 680 |
| Internal wiki links on the page | 19 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | medical |
| Indexing by robots | Allowed |
Edit history
| Page creator | SemaglutideSasha |
|---|---|
| Date of page creation | 20 November 2024 |
| Latest editor | SurvodutideSaff |
| Date of latest edit | 20 July 2026 |
| Total number of edits | 28 |
| Total number of distinct authors | 23 |
| Minor edits | 12 |
| Automated (bot) edits | 5 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 5 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| SemaglutideSasha | 2 | 7.1% | GLP-1 receptor agonists and related compounds |
| CategoryBot | 2 | 7.1% | categorisation and navigation |
| LiraLotte | 2 | 7.1% | GLP-1 receptor agonists and related compounds |
| TimelineTiernan | 2 | 7.1% | GLP-1 receptor agonists and related compounds |
| SurvodutideSaff | 2 | 7.1% | GLP-1 receptor agonists and related compounds |
| RetatrutideRuben | 1 | 3.6% | GLP-1 receptor agonists and related compounds |
| BalanceBirdie | 1 | 3.6% | policy, notability and deletion |
| DPP4_Dagmar | 1 | 3.6% | incretin biology and receptor pharmacology |
| ArchiveBot | 1 | 3.6% | policy, notability and deletion |
| MassSpecMarv | 1 | 3.6% | analytical chemistry and chromatography |
| Chromatokid | 1 | 3.6% | analytical chemistry and chromatography |
| ComparisonCato | 1 | 3.6% | GLP-1 receptor agonists and related compounds |
Category membership
- Category:Small-molecule incretin agonists — 1 member pages
- Category:Compounds and pharmacology — 11 member pages
- Category:Articles describing unapproved compounds — 21 member pages
- Category:Articles describing unapproved compounds (maintenance)